National patent granted
The national patent entitled „Platinum diiodido-complexes with ω-substituted derivatives of 6-alkyloxy-9-deazapurine and the use of these complexes for the preparation of drugs in the antitumor therapy“ (CZ 306966 B6, inventors: Trávníček, Z.; Vančo, J.; Gáliková, J.; Křikavová, R.; Dvořák, Z.) was granted on October 10, 2017 to the team led by Prof. Zdeněk Trávníček, and protects the use of the highly anticancer effective platinum complexes with the general formula cis-[PtI2(Ln)2], where Ln denotes the O-substituted derivatives of 9-deazahypoxanthine, for the treatment of cancer, especially for the treatment of adenocarcinoma of the breast and/or osteosarcoma and/or lung carcinoma and/or malignant melanoma and/or cervical carcinoma and/or prostate carcinoma and/or hepatocellular carcinoma and/or prostate carcinoma and/or ovarian carcinoma and/or cisplatin-resistant ovarian carcinoma.